Literature DB >> 12243978

Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation.

M Mohty1, B Gaugler, C Faucher, D Sainty, M Lafage-Pochitaloff, N Vey, R Bouabdallah, C Arnoulet, J A Gastaut, F Viret, J Wolfers, D Maraninchi, D Blaise, D Olive.   

Abstract

Approaches using reduced conditioning regimens have been developed to obtain minimal procedure-related toxicity. Such novel therapeutic options are being explored with good preliminary results concerning feasibility and engraftment. However, many aspects remain under-evaluated and few data are available about immune and dendritic cell (DC) reconstitution after these highly immunosuppressive regimens. We present here our data in 20 patients receiving allogeneic bone marrow transplantation (allo-BMT) using a reduced preparative regimen. We evaluated in the first 3 months following allo-BMT, several immunological parameters including DC subsets, and compared these to historical results obtained in a group of myeloablative allo-BMT patients. We found an early recovery of leukocytes, CD8+ and NK lymphocytes. We also found a trend towards an improved B cell recovery. These results are somewhat in contrast to the altered immune recovery observed in the myeloablative setting. In addition, we found a significant early circulating DC recovery. Circulating blood DCs were also found to be of full donor origin as assessed by FISH in sex-mismatched pairs. Nevertheless, naive CD4 + CD45RA + T cells were found to be profoundly reduced following such regimens.Collectively, these data further enhance the overall benefits of reduced intensity regimens and the need for a stringent biological monitoring for assessment of the potential advantages of reduced intensity allo-BMT in comparison with conventional allo-BMT.

Entities:  

Mesh:

Year:  2002        PMID: 12243978     DOI: 10.1080/10245330210000013898

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  4 in total

1.  A novel method to quantify and characterize leukemia-reactive natural killer cells in patients undergoing allogeneic hematopoietic stem cell transplantation following conventional or reduced-dose conditioning.

Authors:  Olaf Penack; Lars Fischer; Andrea Stroux; Chiara Gentilini; Axel Nogai; Arne Muessig; Susanne Ganepola; Thoralf Lange; Constanze Kliem; Olga Marinets; Igor Wolfgang Blau; Eckhard Thiel; Lutz Uhareka
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

Review 2.  Targeting natural killer cells and natural killer T cells in cancer.

Authors:  Eric Vivier; Sophie Ugolini; Didier Blaise; Christian Chabannon; Laurent Brossay
Journal:  Nat Rev Immunol       Date:  2012-03-22       Impact factor: 53.106

3.  Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys.

Authors:  Nichole R Klatt; Francois Villinger; Pavel Bostik; Shari N Gordon; Lara Pereira; Jessica C Engram; Ann Mayne; Richard M Dunham; Benton Lawson; Sarah J Ratcliffe; Donald L Sodora; James Else; Keith Reimann; Silvija I Staprans; Ashley T Haase; Jacob D Estes; Guido Silvestri; Aftab A Ansari
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 4.  Considerations in Preparative Regimen Selection to Minimize Rejection in Pediatric Hematopoietic Transplantation in Non-Malignant Diseases.

Authors:  Robert J Hayashi
Journal:  Front Immunol       Date:  2020-10-19       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.